Foresee Pharmaceuticals Co., Ltd. (TPEX: 6576)

Foresee Pharmaceuticals Revenue

Foresee Pharmaceuticals had revenue of 94.18M TWD in the quarter ending June 30, 2024, with 151.24% growth. This brings the company's revenue in the last twelve months to 327.18M, up 248.98% year-over-year. In the year 2023, Foresee Pharmaceuticals had annual revenue of 195.04M, down -35.31%.

• Revenue (ttm): 327.18M
• Revenue Growth: +248.98%
• P/S Ratio: 32.53
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 10.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	195.04M	-106.47M	-35.31%
Dec 31, 2022	301.51M	75.48M	33.39%
Dec 31, 2021	226.03M	-4.41M	-1.91%
Dec 31, 2020	230.44M	155.24M	206.44%
Dec 31, 2019	75.20M	49.16M	188.82%